46.46.Z - Wholesale trade of pharmaceutical and medical products
38.12.Z - Collection of hazardous waste
38.22.Z - Energy recovery
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
82.99.Z - Other business support activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,4 | 0,5 | 29,2 |
Gross profit (loss) | 0,4 | 0,4 | 0,6 | 35,2 |
EBITDA | 0,4 | 0,4 | 0,6 | 27,5 |
Short time liabilities | 0,5 | 0,5 | 0,5 | -1,6 |
Other operating costs | 0,1 | 0 | 0 | 22,6 |
Equity capital | 0,5 | 0,6 | 0,7 | 11 |
Operating profit (EBIT) | 0,4 | 0,4 | 0,6 | 31,8 |
Assets | 1 | 1,1 | 1,2 | 5,1 |
Net profit (loss) | 0,4 | 0,4 | 0,5 | 35,8 |
Cash | 0,4 | 0,5 | 0,5 | -3,3 |
Net income from sale | 4,4 | 3,9 | 3,7 | -6,1 |
Liabilities and provisions for liabilities | 0,5 | 0,5 | 0,5 | -1,6 |
Working assets | 1 | 1,1 | 1,2 | 5,1 |
Other income costs | 0 | 0 | 0,1 | 47,3 |
Depreciation | 0 | 0 | 0 | -59,7 |
% | % | % | p.p. | |
Profitability of capital | 72,1 | 63,6 | 77,9 | 14,3 |
Equity capital to total assets | 50,4 | 53,5 | 56,5 | 3 |
Gross profit margin | 9,5 | 10,5 | 15,2 | 4,7 |
EBITDA Margin | 9,8 | 11,3 | 15,4 | 4,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 48 | 50 | 2 |
Current financial liquidity indicator | 2.0073447227478027 | 2.150420904159546 | 2.2981643676757812 | 0,1 |
Net dept to EBITDA | -0.985956609249115 | -1.1290701627731323 | -0.8557681441307068 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane